RecruitingNCT07291427

Chronic Subdural Hematoma Embolization With Detachable Coils

Safety and Efficacy of Chronic Subdural Hematoma Embolization With Detachable Coils

Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

150 participants

Start Date

Jun 2, 2026

Study Type

OBSERVATIONAL

Conditions

Chronic Subdural Hemorrhage (cSDH)

Summary

This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Balt coils: (Balt USA, LLC) and a procedure called MMA embolization for people with chronic subdural hemorrhage (csdh). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBalt coils: (Balt USA, LLC)

MMA embolization utilizing Balt Coils

PROCEDUREMMA embolization

surgical or bedside evacuation pre or post-surgical debridement

Locations(1)

Mount Sinai Hospital

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07291427